Latest Novartis Stories
ANDERNACH, Germany, July 17, 2014 /PRNewswire/ -- - LTS: market leader in transdermal patches completely acquired by dievini Hopp The supervisory board ("Aufsichtsrat")
Pharmaceutical giant Novartis has licensed the Google-developed smart contact lens designed to help diabetics monitor their blood glucose levels, various media outlets reported on Tuesday.
DUBLIN, July 14, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the
- Designation supports the advancement of CTL019 to help address the unmet need of patients with relapsed/refractory acute lymphoblastic leukemia (r/r ALL) EAST HANOVER, N.J., July 7, 2014
Researchers from the UK and Germany have opened the door on the little understood subject of just how psychedelic substances work within and affect our brain and our perception of consciousness.
InSilico Medicine, Inc.
MarketReportsOnline.com adds "Alzheimer’s Disease Patients & Market Worldwide, Future Scenario (2010 – 2015) & Drugs Analysis" report to its research store. Dallas,
HAMPTON, N.J., July 1, 2014 /PRNewswire/ -- Bellerophon Therapeutics, LLC, a clinical stage biotherapeutics company, leveraging its proprietary drug-device technology platform for the development
LONDON, July 1, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
Receives first-to-file FDA approval, with 180-day marketing exclusivity for generic version in the treatment of hypertension and heart failure NEW BRUNSWICK, N.J., June 27, 2014 /PRNewswire/
- The act of sweetening by admixture of some saccharine substance.